Akso Health Group ADR (AHG) - Net Assets
Based on the latest financial reports, Akso Health Group ADR (AHG) has net assets worth $198.31 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($212.04 Million) and total liabilities ($13.73 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Akso Health Group ADR asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $198.31 Million |
| % of Total Assets | 93.52% |
| Annual Growth Rate | 50.45% |
| 5-Year Change | 1053.06% |
| 10-Year Change | 1321.29% |
| Growth Volatility | 450.42 |
Akso Health Group ADR - Net Assets Trend (2015–2025)
This chart illustrates how Akso Health Group ADR's net assets have evolved over time, based on quarterly financial data. Also explore AHG total asset value for the complete picture of this company's asset base.
Annual Net Assets for Akso Health Group ADR (2015–2025)
The table below shows the annual net assets of Akso Health Group ADR from 2015 to 2025. For live valuation and market cap data, see market cap of Akso Health Group ADR.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $199.15 Million | +43.87% |
| 2024-03-31 | $138.42 Million | +1465.97% |
| 2023-03-31 | $8.84 Million | -28.05% |
| 2022-03-31 | $12.29 Million | -28.87% |
| 2021-03-31 | $17.27 Million | -64.09% |
| 2020-03-31 | $48.10 Million | -61.98% |
| 2019-03-31 | $126.50 Million | -9.67% |
| 2018-03-31 | $140.04 Million | +495.82% |
| 2017-03-31 | $23.50 Million | +67.74% |
| 2016-03-31 | $14.01 Million | +318.22% |
| 2015-03-31 | $3.35 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Akso Health Group ADR's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 19855358100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $165.68K | 0.08% |
| Other Comprehensive Income | $-3.77 Million | -1.89% |
| Other Components | $401.63 Million | 201.70% |
| Total Equity | $199.12 Million | 100.00% |
Akso Health Group ADR Competitors by Market Cap
The table below lists competitors of Akso Health Group ADR ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Run Long Construction Co Ltd
TW:1808
|
$807.49 Million |
|
Shenzhen Prince New Materials Co Ltd
SHE:002735
|
$807.75 Million |
|
Shanxi Huhua Group Co Ltd
SHE:003002
|
$808.04 Million |
|
Shanghai Urban Architecture Design Co. Ltd.
SHE:300983
|
$808.65 Million |
|
Tae Kwang Corporation
KQ:023160
|
$807.25 Million |
|
Shanghai Maling Aquarius Co Ltd
SHG:600073
|
$806.85 Million |
|
Costar Group Co Ltd
SHE:002189
|
$806.48 Million |
|
Johns LYNG Group Ltd
AU:JLG
|
$806.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Akso Health Group ADR's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 138,367,384 to 199,119,145, a change of 60,751,761 (43.9%).
- Net loss of 134,977,369 reduced equity.
- New share issuances of 195,884,024 increased equity.
- Other comprehensive income increased equity by 315,213.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-134.98 Million | -67.79% |
| Share Issuances | $195.88 Million | +98.38% |
| Other Comprehensive Income | $315.21K | +0.16% |
| Other Changes | $-470.11K | -0.24% |
| Total Change | $- | 43.91% |
Book Value vs Market Value Analysis
This analysis compares Akso Health Group ADR's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.04x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 3.37x to 3.04x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-03-31 | $0.63 | $2.12 | x |
| 2016-03-31 | $2.63 | $2.12 | x |
| 2017-03-31 | $4.41 | $2.12 | x |
| 2018-03-31 | $26.45 | $2.12 | x |
| 2019-03-31 | $21.52 | $2.12 | x |
| 2020-03-31 | $8.88 | $2.12 | x |
| 2021-03-31 | $3.18 | $2.12 | x |
| 2022-03-31 | $0.62 | $2.12 | x |
| 2023-03-31 | $1.14 | $2.12 | x |
| 2024-03-31 | $5.81 | $2.12 | x |
| 2025-03-31 | $0.70 | $2.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Akso Health Group ADR utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -67.79%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -913.38%
- • Asset Turnover: 0.07x
- • Equity Multiplier: 1.08x
- Recent ROE (-67.79%) is below the historical average (-43.15%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -10.45% | -7.54% | 0.63x | 2.21x | $-685.21K |
| 2016 | 25.25% | 29.75% | 0.53x | 1.60x | $2.14 Million |
| 2017 | 36.47% | 37.39% | 0.81x | 1.21x | $6.22 Million |
| 2018 | 46.76% | 61.05% | 0.65x | 1.17x | $51.48 Million |
| 2019 | 4.37% | 9.02% | 0.35x | 1.37x | $-7.12 Million |
| 2020 | -148.02% | -1029.70% | 0.09x | 1.67x | $-76.01 Million |
| 2021 | -201.64% | -1984.52% | 0.06x | 1.83x | $-36.55 Million |
| 2022 | -137.17% | -266.99% | 0.12x | 4.13x | $-18.08 Million |
| 2023 | -15.59% | -10.32% | 0.64x | 2.34x | $-2.23 Million |
| 2024 | -6.84% | -391.78% | 0.02x | 1.03x | $-23.30 Million |
| 2025 | -67.79% | -913.38% | 0.07x | 1.08x | $-154.89 Million |
Industry Comparison
This section compares Akso Health Group ADR's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,190,627,521
- Average return on equity (ROE) among peers: -3.20%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Akso Health Group ADR (AHG) | $198.31 Million | -10.45% | 0.07x | $807.33 Million |
| Accendra Health Inc (ACH) | $565.23 Million | -64.17% | 7.24x | $147.73 Million |
| Cardinal Health Inc (CAH) | $54.00 Million | 12.22% | 2.53x | $45.94 Billion |
| Cencora Inc. (COR) | $75.30 Million | 67.07% | 19.61x | $59.14 Billion |
| Cosmos Health Inc. (COSM) | $-53.68K | 0.00% | 0.00x | $10.83 Million |
| EDAP TMS SA (EDAP) | $19.41 Million | -151.12% | 3.07x | $126.31 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $1.41 Million | 82.70% | 1.73x | $143.05 Million |
| Henry Schein Inc (HSIC) | $3.66 Billion | 0.00% | 1.14x | $8.70 Billion |
| McKesson Corporation (MCK) | $6.27 Billion | 15.35% | 2.82x | $99.71 Billion |
| Owens & Minor Inc (OMI) | $70.80 Million | 9.18% | 1.18x | $185.63 Million |
About Akso Health Group ADR
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The compan… Read more